Endocrine pancreatic morphology and function in exocrine insufficiency in rats

Area of Science:

• Endocrinology
• Gastroenterology
• Physiology

Background:

• Exocrine pancreatic insufficiency (EPI) is a condition characterized by the inability of the pancreas to produce or secrete sufficient digestive enzymes.
• The pancreas has both exocrine and endocrine functions, with the islets of Langerhans responsible for hormone production like insulin.
• The relationship between exocrine pancreatic function and endocrine pancreatic function, particularly insulin secretion, is not fully understood.

Purpose of the Study:

• To investigate the impact of induced exocrine pancreatic insufficiency on insulin secretion and glucose tolerance in rats.
• To determine if exocrine atrophy affects the structure and cell composition of the islets of Langerhans.
• To assess the dynamic insulin response in isolated perfused pancreases and glucose tolerance in vivo.

Main Methods:

• Exocrine pancreatic insufficiency was induced in rats using oleic acid injection into the pancreatic duct.
• Histological analysis was performed to assess exocrine tissue reduction and islet cell distribution.
• Insulin release was measured from isolated perfused pancreases stimulated by glucose and arginine, and oral and intravenous glucose tolerance tests were conducted in vivo.

Main Results:

• Induction of EPI led to a 98% reduction in exocrine pancreatic tissue, while islets of Langerhans remained intact.
• In isolated perfused pancreases, glucose- and arginine-stimulated insulin release was significantly reduced in rats with EPI.
• Despite reduced insulin secretion in vitro, oral and intravenous glucose tolerance tests in vivo showed only a slight impairment in glucose tolerance, with no significant differences in serum glucose or insulin levels compared to controls.

Conclusions:

• Induced exocrine pancreatic insufficiency in rats leads to significant reductions in stimulated insulin release from the pancreas.
• The findings suggest a functional link between the exocrine pancreas and the endocrine pancreas's ability to secrete insulin.
• While in vitro studies show impaired insulin release, in vivo glucose tolerance tests reveal a less pronounced effect, indicating potential compensatory mechanisms or limitations of the models used.